Chromatin-Independent Binding of Serum Amyloid P Component to Apoptotic Cells
Human serum amyloid P component (SAP) is a glycoprotein structurally belonging to the pentraxin family of proteins, which has a characteristic pentameric organization. Mice with a targeted deletion of the SAP gene develop antinuclear Abs, which was interpreted as evidence for a role of SAP in contro...
Saved in:
Published in: | The Journal of immunology (1950) Vol. 167; no. 2; pp. 647 - 654 |
---|---|
Main Authors: | , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
Am Assoc Immnol
15-07-2001
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Human serum amyloid P component (SAP) is a glycoprotein structurally belonging to the pentraxin family of proteins, which has a characteristic pentameric organization. Mice with a targeted deletion of the SAP gene develop antinuclear Abs, which was interpreted as evidence for a role of SAP in controlling the degradation of chromatin. However, in vitro SAP also can bind to phosphatidylethanolamine, a phospholipid which in normal cells is located mainly in the inner leaflet of the cell membrane, to be translocated to the outer leaflet of the cell membrane during a membrane flip-flop. We hypothesized that SAP, because of its specificity for phosphatidylethanolamine, may bind to apoptotic cells independent of its nuclear binding. Calcium-dependent binding of SAP to early, nonpermeable apoptotic Jurkat, SKW, and Raji cells was indeed observed. Experiments with flip-flopped erythrocytes confirmed that SAP bound to early apoptotic cells via exposed phosphatidylethanolamine. Binding of SAP was stronger to late, permeable apoptotic cells. Experiments with enucleated neutrophils, with DNase/RNase treatment of late apoptotic Jurkat cells, and competition experiments with histones suggested that binding of SAP to late apoptotic cells was largely independent of chromatin. Confocal laser microscopic studies indeed suggested that SAP bound to these apoptotic cells mainly via the blebs. Thus, this study shows that SAP binds to apoptotic cells already at an early stage, which raises the possibility that SAP is involved in dealing with apoptotic cells in vivo. |
---|---|
AbstractList | Human serum amyloid P component (SAP) is a glycoprotein structurally belonging to the pentraxin family of proteins, which has a characteristic pentameric organization. Mice with a targeted deletion of the SAP gene develop antinuclear Abs, which was interpreted as evidence for a role of SAP in controlling the degradation of chromatin. However, in vitro SAP also can bind to phosphatidylethanolamine, a phospholipid which in normal cells is located mainly in the inner leaflet of the cell membrane, to be translocated to the outer leaflet of the cell membrane during a membrane flip-flop. We hypothesized that SAP, because of its specificity for phosphatidylethanolamine, may bind to apoptotic cells independent of its nuclear binding. Calcium-dependent binding of SAP to early, nonpermeable apoptotic Jurkat, SKW, and Raji cells was indeed observed. Experiments with flip-flopped erythrocytes confirmed that SAP bound to early apoptotic cells via exposed phosphatidylethanolamine. Binding of SAP was stronger to late, permeable apoptotic cells. Experiments with enucleated neutrophils, with DNase/RNase treatment of late apoptotic Jurkat cells, and competition experiments with histones suggested that binding of SAP to late apoptotic cells was largely independent of chromatin. Confocal laser microscopic studies indeed suggested that SAP bound to these apoptotic cells mainly via the blebs. Thus, this study shows that SAP binds to apoptotic cells already at an early stage, which raises the possibility that SAP is involved in dealing with apoptotic cells in vivo. Abstract Human serum amyloid P component (SAP) is a glycoprotein structurally belonging to the pentraxin family of proteins, which has a characteristic pentameric organization. Mice with a targeted deletion of the SAP gene develop antinuclear Abs, which was interpreted as evidence for a role of SAP in controlling the degradation of chromatin. However, in vitro SAP also can bind to phosphatidylethanolamine, a phospholipid which in normal cells is located mainly in the inner leaflet of the cell membrane, to be translocated to the outer leaflet of the cell membrane during a membrane flip-flop. We hypothesized that SAP, because of its specificity for phosphatidylethanolamine, may bind to apoptotic cells independent of its nuclear binding. Calcium-dependent binding of SAP to early, nonpermeable apoptotic Jurkat, SKW, and Raji cells was indeed observed. Experiments with flip-flopped erythrocytes confirmed that SAP bound to early apoptotic cells via exposed phosphatidylethanolamine. Binding of SAP was stronger to late, permeable apoptotic cells. Experiments with enucleated neutrophils, with DNase/RNase treatment of late apoptotic Jurkat cells, and competition experiments with histones suggested that binding of SAP to late apoptotic cells was largely independent of chromatin. Confocal laser microscopic studies indeed suggested that SAP bound to these apoptotic cells mainly via the blebs. Thus, this study shows that SAP binds to apoptotic cells already at an early stage, which raises the possibility that SAP is involved in dealing with apoptotic cells in vivo. |
Author | Hordijk, Peter L Huisman, Han G Hack, C. Erik Rensink, Irma Aarden, Lucien A Zwart, Bas Roem, Dorina Familian, Atoosa |
Author_xml | – sequence: 1 fullname: Familian, Atoosa – sequence: 2 fullname: Zwart, Bas – sequence: 3 fullname: Huisman, Han G – sequence: 4 fullname: Rensink, Irma – sequence: 5 fullname: Roem, Dorina – sequence: 6 fullname: Hordijk, Peter L – sequence: 7 fullname: Aarden, Lucien A – sequence: 8 fullname: Hack, C. Erik |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/11441067$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkMtOwzAQRS1URB_wAyxQVuxSbMePZFkiHpVAIAFry42d1lVshzhR1b_HqEVdsvHI0pk7M2cKRs47DcA1gnMCSXG3NdYOzjdzxPgczxnhZ2CCKIUpY5CNwARCjFPEGR-DaQhbCCGDmFyAMUKEIMj4BLyWm85b2RuXLp3SrY6P65N745Rx68TXyYfuBpss7L7xRiXvSeltG_eIUO-TRevb3vemSkrdNOESnNeyCfrqWGfg6_Hhs3xOX96eluXiJa0IR32ayxzxFcUVrElBKpLTLBaVM5YxqqhChYS0KuIRtFKZrOMH5xIRmim0WmGVzcDtIbft_PegQy-sCVXcQDrthyA4LArOKfoXRLzAGcM0gvgAVp0PodO1aDtjZbcXCIpf2-LPtoi2BRbRdmy6OaYPK6vVqeWo9zR-Y9abnem0CFY2TcSR2O12p6QfidaLbg |
CitedBy_id | crossref_primary_10_1016_j_coi_2005_11_009 crossref_primary_10_1111_j_1365_2567_2004_01860_x crossref_primary_10_1371_journal_pone_0055766 crossref_primary_10_1002_art_20847 crossref_primary_10_1080_08916934_2018_1523395 crossref_primary_10_1111_j_1365_2605_2007_00800_x crossref_primary_10_1016_j_clim_2010_01_002 crossref_primary_10_1146_annurev_pathol_020712_163930 crossref_primary_10_1007_s12263_007_0058_x crossref_primary_10_1016_j_molimm_2004_07_045 crossref_primary_10_4049_jimmunol_0904016 crossref_primary_10_1586_1744666X_2_2_237 crossref_primary_10_3389_fimmu_2018_00892 crossref_primary_10_1016_j_imbio_2006_11_005 crossref_primary_10_1002_art_23553 crossref_primary_10_1002_eji_200425045 crossref_primary_10_1006_jaut_2002_0615 crossref_primary_10_1146_annurev_immunol_23_021704_115756 crossref_primary_10_4049_jimmunol_169_5_2580 crossref_primary_10_4155_cli_11_155 crossref_primary_10_1039_b709439f crossref_primary_10_1016_j_semarthrit_2008_03_006 crossref_primary_10_1096_fj_02_1036com crossref_primary_10_1016_j_rdc_2004_04_009 crossref_primary_10_1016_j_cellimm_2006_02_006 crossref_primary_10_3324_haematol_2022_282411 crossref_primary_10_1002_art_20034 crossref_primary_10_1096_fj_08_110429 crossref_primary_10_1002_prca_200600494 crossref_primary_10_1016_j_febslet_2007_10_037 crossref_primary_10_1074_jbc_M111_299545 crossref_primary_10_1196_annals_1422_025 crossref_primary_10_1016_j_rdc_2004_04_001 crossref_primary_10_4049_jimmunol_172_11_6692 crossref_primary_10_1126_scitranslmed_3000111 crossref_primary_10_1128_JVI_00082_09 crossref_primary_10_1097_MEG_0b013e32835ac77a crossref_primary_10_1016_S0002_9440_10_63895_3 crossref_primary_10_1016_j_placenta_2007_02_008 crossref_primary_10_1007_s11882_013_0377_5 crossref_primary_10_1189_jlb_0211095 crossref_primary_10_1016_j_alit_2017_03_008 crossref_primary_10_1016_j_bbadis_2006_07_011 crossref_primary_10_1016_j_jprot_2013_04_033 crossref_primary_10_1002_jnr_23616 crossref_primary_10_4049_jimmunol_169_1_159 crossref_primary_10_1007_s11655_016_2472_7 crossref_primary_10_1136_annrheumdis_2013_203844 crossref_primary_10_1038_nri957 crossref_primary_10_1016_S1471_4906_03_00030_9 crossref_primary_10_1016_j_clim_2004_02_017 crossref_primary_10_1111_j_1365_2249_2003_02330_x crossref_primary_10_1093_rheumatology_keh693 crossref_primary_10_4137_JCD_S11037 crossref_primary_10_1002_art_10744 crossref_primary_10_1002_immu_200310022 crossref_primary_10_1074_jbc_M405147200 crossref_primary_10_3892_br_2020_1276 crossref_primary_10_1016_j_biocel_2010_10_013 crossref_primary_10_4049_jimmunol_172_3_1882 crossref_primary_10_1097_01_shk_0000108398_56565_ae crossref_primary_10_1002_eji_200424904 crossref_primary_10_1182_blood_2005_03_1112 crossref_primary_10_1186_1477_7827_8_6 crossref_primary_10_1517_14712598_2_3_249 crossref_primary_10_1016_S1471_4906_03_00026_7 crossref_primary_10_1196_annals_1361_041 crossref_primary_10_1080_0891693042000196183 crossref_primary_10_1002_art_10737 crossref_primary_10_1002_art_20370 crossref_primary_10_1038_cddis_2016_113 crossref_primary_10_1371_journal_pbio_0020243 crossref_primary_10_1002_art_11025 crossref_primary_10_1016_j_biomaterials_2012_11_020 crossref_primary_10_1016_j_intimp_2019_106134 crossref_primary_10_1038_ncprheum0290 crossref_primary_10_1080_0891693042000196219 crossref_primary_10_1097_00001574_200403000_00015 crossref_primary_10_1177_0267659110385742 |
Cites_doi | 10.1016/0161-5890(86)90003-9 10.1016/S0074-7696(08)62312-8 10.1016/S0065-2776(08)60379-X 10.1016/0167-5699(94)90138-4 10.1182/blood.V84.5.1415.1415 10.1007/BF00163818 10.1016/S0021-9258(19)75657-9 10.4049/jimmunol.150.1.169 10.1016/0006-291X(87)91111-9 10.1084/jem.152.5.1162 10.1016/S0167-5699(97)01002-5 10.1084/jem.170.4.1433 10.1073/pnas.81.12.3751 10.1038/ng0598-56 10.1111/j.1749-6632.1982.tb22138.x 10.4049/jimmunol.149.11.3689 10.1084/jem.179.4.1317 10.1016/S0065-2776(08)60822-6 10.1046/j.1365-3083.1996.d01-326.x 10.1021/bi00341a019 10.1002/(SICI)1097-0320(19970101)27:1<1::AID-CYTO2>3.0.CO;2-L 10.1016/0076-6879(88)63048-5 10.4049/jimmunol.149.12.4029 10.1111/j.1365-2249.1994.tb06594.x 10.1016/S0021-9258(18)45804-8 10.1074/jbc.271.25.14897 10.1038/9544 10.1038/sj.leu.2401061 10.1182/blood.V89.4.1121 10.1016/S0021-9258(18)98779-X 10.1083/jcb.97.2.368 10.1038/293652a0 10.1021/bi00135a023 10.1084/jem.172.1.13 10.4049/jimmunol.148.7.2207 10.1084/jem.192.9.1353 10.4049/jimmunol.158.10.4525 10.1021/bi00390a031 10.1074/S0021-9258(19)78482-8 10.1038/343170a0 10.1038/367338a0 10.1084/jem.182.5.1545 10.1016/S0022-2143(97)90093-7 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T5 H94 7X8 |
DOI | 10.4049/jimmunol.167.2.647 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Immunology Abstracts AIDS and Cancer Research Abstracts MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef AIDS and Cancer Research Abstracts Immunology Abstracts MEDLINE - Academic |
DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1550-6606 |
EndPage | 654 |
ExternalDocumentID | 10_4049_jimmunol_167_2_647 11441067 www167_2_647 |
Genre | Journal Article |
GroupedDBID | - 08R 2WC 34G 39C 3O- 53G 55 5GY 5RE 5VS 79B 85S 8RP AALRV AARDX ABEFU ABFLS ABOCM ABPPZ ABPTK ACGFS ACIWK ACNCT ACPRK ADACO ADBBV ADKFC AENEX AETEA AFFNX AFRAH AJYGW ALMA_UNASSIGNED_HOLDINGS BAWUL D0L DIK DU5 E3Z EBS EJD F5P FH7 FRP G8K GJ GX1 IH2 J5H K-O K78 KQ8 L7B MVM MYA NEJ O0- OK1 P0W P2P PQEST PQQKQ R.V RHF RHI RZQ SJN TWZ VH1 WH7 WOQ X X7M XFK XJT YCJ ZA5 ZE2 ZGI ZXP --- -~X .55 .GJ 18M ABCQX ABJNI ACGFO ADNWM AFHIN AFOSN AHWXS AI. AIZAD BTFSW CGR CUY CVF ECM EIF NPM TR2 W8F WHG XSW XTH YHG AAYXX CITATION 7T5 H94 7X8 |
ID | FETCH-LOGICAL-c471t-8a817b52c0f494c485394cd866365d5d19a05c96065cd3af05c28a1453d1bb2d3 |
ISSN | 0022-1767 |
IngestDate | Fri Oct 25 05:47:35 EDT 2024 Fri Oct 25 05:41:34 EDT 2024 Thu Sep 26 18:30:58 EDT 2024 Sat Sep 28 08:38:42 EDT 2024 Tue Nov 10 19:47:56 EST 2020 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c471t-8a817b52c0f494c485394cd866365d5d19a05c96065cd3af05c28a1453d1bb2d3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
OpenAccessLink | https://www.jimmunol.org/content/jimmunol/167/2/647.full.pdf |
PMID | 11441067 |
PQID | 17923625 |
PQPubID | 23462 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_70997751 proquest_miscellaneous_17923625 crossref_primary_10_4049_jimmunol_167_2_647 pubmed_primary_11441067 highwire_smallpub1_www167_2_647 |
ProviderPackageCode | RHF RHI |
PublicationCentury | 2000 |
PublicationDate | 20010715 2001-Jul-15 2001-07-15 |
PublicationDateYYYYMMDD | 2001-07-15 |
PublicationDate_xml | – month: 07 year: 2001 text: 20010715 day: 15 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | The Journal of immunology (1950) |
PublicationTitleAlternate | J Immunol |
PublicationYear | 2001 |
Publisher | Am Assoc Immnol |
Publisher_xml | – name: Am Assoc Immnol |
References | 2022123115560479600_R18 2022123115560479600_R19 2022123115560479600_R14 2022123115560479600_R36 2022123115560479600_R15 2022123115560479600_R37 2022123115560479600_R16 2022123115560479600_R38 2022123115560479600_R17 2022123115560479600_R39 2022123115560479600_R10 2022123115560479600_R32 2022123115560479600_R11 2022123115560479600_R33 2022123115560479600_R12 2022123115560479600_R34 2022123115560479600_R13 2022123115560479600_R35 2022123115560479600_R2 2022123115560479600_R1 2022123115560479600_R40 2022123115560479600_R4 2022123115560479600_R41 2022123115560479600_R3 2022123115560479600_R20 2022123115560479600_R42 2022123115560479600_R6 2022123115560479600_R5 2022123115560479600_R8 2022123115560479600_R7 2022123115560479600_R9 2022123115560479600_R29 2022123115560479600_R25 2022123115560479600_R26 2022123115560479600_R27 2022123115560479600_R28 2022123115560479600_R21 2022123115560479600_R43 2022123115560479600_R22 2022123115560479600_R44 2022123115560479600_R23 2022123115560479600_R45 2022123115560479600_R24 2022123115560479600_R30 2022123115560479600_R31 |
References_xml | – ident: 2022123115560479600_R10 doi: 10.1016/0161-5890(86)90003-9 – ident: 2022123115560479600_R24 doi: 10.1016/S0074-7696(08)62312-8 – ident: 2022123115560479600_R1 doi: 10.1016/S0065-2776(08)60379-X – ident: 2022123115560479600_R3 doi: 10.1016/0167-5699(94)90138-4 – ident: 2022123115560479600_R4 – ident: 2022123115560479600_R37 doi: 10.1182/blood.V84.5.1415.1415 – ident: 2022123115560479600_R6 doi: 10.1007/BF00163818 – ident: 2022123115560479600_R9 doi: 10.1016/S0021-9258(19)75657-9 – ident: 2022123115560479600_R33 doi: 10.4049/jimmunol.150.1.169 – ident: 2022123115560479600_R18 doi: 10.1016/0006-291X(87)91111-9 – ident: 2022123115560479600_R5 doi: 10.1084/jem.152.5.1162 – ident: 2022123115560479600_R38 doi: 10.1016/S0167-5699(97)01002-5 – ident: 2022123115560479600_R19 doi: 10.1084/jem.170.4.1433 – ident: 2022123115560479600_R28 doi: 10.1073/pnas.81.12.3751 – ident: 2022123115560479600_R44 doi: 10.1038/ng0598-56 – ident: 2022123115560479600_R8 doi: 10.1111/j.1749-6632.1982.tb22138.x – ident: 2022123115560479600_R22 doi: 10.4049/jimmunol.149.11.3689 – ident: 2022123115560479600_R45 doi: 10.1084/jem.179.4.1317 – ident: 2022123115560479600_R25 doi: 10.1016/S0065-2776(08)60822-6 – ident: 2022123115560479600_R39 – ident: 2022123115560479600_R11 doi: 10.1046/j.1365-3083.1996.d01-326.x – ident: 2022123115560479600_R29 doi: 10.1021/bi00341a019 – ident: 2022123115560479600_R27 doi: 10.1002/(SICI)1097-0320(19970101)27:1<1::AID-CYTO2>3.0.CO;2-L – ident: 2022123115560479600_R2 doi: 10.1016/0076-6879(88)63048-5 – ident: 2022123115560479600_R42 doi: 10.4049/jimmunol.149.12.4029 – ident: 2022123115560479600_R20 doi: 10.1111/j.1365-2249.1994.tb06594.x – ident: 2022123115560479600_R12 doi: 10.1016/S0021-9258(18)45804-8 – ident: 2022123115560479600_R15 doi: 10.1074/jbc.271.25.14897 – ident: 2022123115560479600_R23 doi: 10.1038/9544 – ident: 2022123115560479600_R26 doi: 10.1038/sj.leu.2401061 – ident: 2022123115560479600_R31 doi: 10.1182/blood.V89.4.1121 – ident: 2022123115560479600_R13 doi: 10.1016/S0021-9258(18)98779-X – ident: 2022123115560479600_R35 doi: 10.1083/jcb.97.2.368 – ident: 2022123115560479600_R7 doi: 10.1038/293652a0 – ident: 2022123115560479600_R17 doi: 10.1021/bi00135a023 – ident: 2022123115560479600_R21 doi: 10.1084/jem.172.1.13 – ident: 2022123115560479600_R41 doi: 10.4049/jimmunol.148.7.2207 – ident: 2022123115560479600_R36 doi: 10.1084/jem.192.9.1353 – ident: 2022123115560479600_R43 doi: 10.4049/jimmunol.158.10.4525 – ident: 2022123115560479600_R30 doi: 10.1021/bi00390a031 – ident: 2022123115560479600_R14 doi: 10.1074/S0021-9258(19)78482-8 – ident: 2022123115560479600_R40 doi: 10.1038/343170a0 – ident: 2022123115560479600_R16 doi: 10.1038/367338a0 – ident: 2022123115560479600_R32 doi: 10.1084/jem.182.5.1545 – ident: 2022123115560479600_R34 doi: 10.1016/S0022-2143(97)90093-7 |
SSID | ssj0006024 |
Score | 2.074856 |
Snippet | Human serum amyloid P component (SAP) is a glycoprotein structurally belonging to the pentraxin family of proteins, which has a characteristic pentameric... Abstract Human serum amyloid P component (SAP) is a glycoprotein structurally belonging to the pentraxin family of proteins, which has a characteristic... |
SourceID | proquest crossref pubmed highwire |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 647 |
SubjectTerms | amyloid P Animals Apoptosis - drug effects Binding, Competitive Cattle Chromatin - physiology Edetic Acid - pharmacology Erythrocyte Membrane - metabolism Humans Jurkat Cells Ligands Neutrophils - metabolism Plasma - metabolism Protein Binding - drug effects Serum Amyloid P-Component - isolation & purification Serum Amyloid P-Component - metabolism Time Factors Tumor Cells, Cultured |
Title | Chromatin-Independent Binding of Serum Amyloid P Component to Apoptotic Cells |
URI | http://www.jimmunol.org/cgi/content/abstract/167/2/647 https://www.ncbi.nlm.nih.gov/pubmed/11441067 https://search.proquest.com/docview/17923625 https://search.proquest.com/docview/70997751 |
Volume | 167 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfYEGgvCMbHOhj4AZ6qlNpxvh730amgrUyskyZeLCdOpIguqdZUFf89d7HzwccEPPCSNK5rJ3e_Xu7OvjtC3gpfxKnPMyeM1NgBgcccxWPPcXWUhK5I00zhiu70MphdhycTMelCCLq2_8ppaANeY-TsP3C7HRQa4DPwHI7AdTj-Fd8x2y1qoYXzoa1wWw2PchO9giEq6S065W_AUs_18KKWCGWBnUANPVyWy6rEJK7H6WKx6quuXRCZyTOBgSUmgdO7epls3HMq1OU0cuNbbSHyZaNMfNBRh6V8ZT2w067I12fcU1987Vy6jVOCobfThGX2ggRYYCpttILWXuY9g9eITd9k3bRvYN-klf5ZuAswZlC42-cbwXAjPmp_2s-kPfskT6_OzuR8cj3fIvc5CCHc7nn5cda-pf0xF00mebxRE1CFc7z_dYYflZYmkfTdRkmtnMwfk0eWLfTQwOEJuZcWu-SBqTP6bZc8PLc7KJ6S89_ig1p80DKjNT6oxQe9oC0-aFXSFh-0xsczcnU6mR9PHVtSw0lAC6mcUIUsiD2ejDMRiUSAsgYnHYLe6Xva0wz-sV6CVq2XaFdlcMFDxYTnahbHXLvPyXYBc-4RmvhcJ1qB-gg6N3wTMa4SFgc68jMvC-MBGTY0k0uTOUWCxYkUlg2FJVBYcgkUHpA3DVklIG-xAHIyudls-j0aaksQgbiupYq0XK8kwxyYYMff3SPA-PDAYwPywrCpuyN0KIDGtv_H0V-SnQ7pr8h2dbtOD8jWSq9f18j6Dqpei1s |
link.rule.ids | 315,782,786,27935,27936 |
linkProvider | Multiple Vendors |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Chromatin-Independent+Binding+of+Serum+Amyloid+P+Component+to+Apoptotic+Cells&rft.jtitle=The+Journal+of+immunology+%281950%29&rft.au=Familian%2C+A&rft.au=Zwart%2C+B&rft.au=Huisman%2C+H+G&rft.au=Rensink%2C+I&rft.date=2001-07-15&rft.issn=0022-1767&rft.volume=167&rft.issue=2&rft.spage=647&rft.epage=654&rft_id=info:doi/10.4049%2Fjimmunol.167.2.647&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1767&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1767&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1767&client=summon |